Clinical Trial Update: Ragweed-SPIRE Follow-On Study

View source ↗

Summary

Circassia Limited reports that the Ragweed-SPIRE follow-on clinical trial has completed. The study targeted rhinoconjunctivitis and ragweed allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ragweed Allergy
• Rhinoconjunctivitis

Drugs mentioned

• Ragweed-SPIRE

Snippet

Sponsor: Circassia Limited | Conditions: Rhinoconjunctivitis, Ragweed Allergy | Status: COMPLETED